UnitedHealth Group Incorporated $UNH Shares Sold by UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC

UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC reduced its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 13.4% during the 1st quarter, Holdings Channel.com reports. The firm owned 7,442,651 shares of the healthcare conglomerate’s stock after selling 1,150,067 shares during the period. UnitedHealth Group makes up approximately 1.0% of UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC’s portfolio, making the stock its 13th largest position. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC’s holdings in UnitedHealth Group were worth $3,898,088,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in the business. Woodline Partners LP boosted its position in shares of UnitedHealth Group by 47.7% in the 1st quarter. Woodline Partners LP now owns 77,751 shares of the healthcare conglomerate’s stock worth $40,722,000 after buying an additional 25,094 shares in the last quarter. Zurich Insurance Group Ltd FI increased its stake in shares of UnitedHealth Group by 3.1% during the 1st quarter. Zurich Insurance Group Ltd FI now owns 197,587 shares of the healthcare conglomerate’s stock valued at $103,486,000 after acquiring an additional 5,964 shares during the last quarter. Empowered Funds LLC increased its stake in shares of UnitedHealth Group by 8.2% during the 1st quarter. Empowered Funds LLC now owns 43,709 shares of the healthcare conglomerate’s stock valued at $22,893,000 after acquiring an additional 3,310 shares during the last quarter. Peloton Wealth Strategists increased its stake in shares of UnitedHealth Group by 1.4% during the 1st quarter. Peloton Wealth Strategists now owns 10,320 shares of the healthcare conglomerate’s stock valued at $5,405,000 after acquiring an additional 147 shares during the last quarter. Finally, Ascent Group LLC increased its stake in shares of UnitedHealth Group by 21.7% in the first quarter. Ascent Group LLC now owns 26,535 shares of the healthcare conglomerate’s stock worth $13,898,000 after buying an additional 4,730 shares during the last quarter. 87.86% of the stock is currently owned by hedge funds and other institutional investors.

UnitedHealth Group Trading Up 1.6%

Shares of UNH opened at $320.46 on Tuesday. The business’s 50-day moving average price is $288.96 and its 200 day moving average price is $371.54. The stock has a market capitalization of $290.24 billion, a P/E ratio of 13.88, a P/E/G ratio of 2.04 and a beta of 0.45. UnitedHealth Group Incorporated has a 1-year low of $234.60 and a 1-year high of $630.73. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%.The business had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. During the same quarter in the previous year, the business posted $6.80 earnings per share. The company’s revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, September 23rd. Investors of record on Monday, September 15th will be paid a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.8%. The ex-dividend date of this dividend is Monday, September 15th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 38.30%.

Wall Street Analyst Weigh In

Several research firms recently issued reports on UNH. Barclays upped their price target on shares of UnitedHealth Group from $337.00 to $352.00 and gave the company an “overweight” rating in a report on Thursday, September 4th. UBS Group reiterated a “buy” rating on shares of UnitedHealth Group in a research note on Thursday, July 17th. Hsbc Global Res cut UnitedHealth Group from a “hold” rating to a “moderate sell” rating in a research note on Wednesday, May 21st. Oppenheimer lowered their price target on UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating on the stock in a report on Wednesday, July 30th. Finally, Wall Street Zen lowered UnitedHealth Group from a “buy” rating to a “hold” rating in a report on Saturday, May 24th. Sixteen investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat, UnitedHealth Group currently has an average rating of “Moderate Buy” and a consensus price target of $354.86.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.